RSV in Infants and High-Risk Children: A Commentary on the Roll-out of a New Preventive Medication
RSV in Infants and High-Risk Children: A Commentary on the Roll-out of a New Preventive Medication https://pediatricsnationwide.org/wp-content/uploads/2018/10/NAS-header-1024x575.jpg 1024 575 Pam Georgiana https://pediatricsnationwide.org/wp-content/uploads/2023/07/May-2023.jpgAccording to the Centers for Disease Control and Prevention (CDC), respiratory syncytial virus (RSV) causes more than 2 million outpatient visits, as many as 80,000 hospitalizations, and 100 to 300 deaths in children under 5 years old annually. Infants under 6 months of age are at the most significant risk of hospitalization. Although the highest…